Twist Bioscience (TWST) total debt

Total debt · fiscal 2026
$94.99M

Twist Bioscience (TWST) carried total debt of $94.99M at the end of fiscal 2026 (September 30, 2026). That is 25.7% higher than the $75.57M of fiscal 2025. Figures as of 18 Nov 2026, 06:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2026
$94.99M
Change on fiscal 2025
+25.7%
Highest on record
$94.99Mfiscal 2026
Lowest on record
$4.74Mfiscal 2020
Fiscal years on record
72018–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Twist Bioscience total debt, in more detail

Across the 7 fiscal years on record (2018–2026), the highest was $94.99M in fiscal 2026 and the lowest $4.74M in fiscal 2020.

Total debt was 0.1× shareholders' equity at the end of fiscal 2026.

History · 7 fiscal years

Total debt by fiscal year

Twist Bioscience total debt, year by year

Twist Bioscience (TWST) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2026$94.99M 25.7% up0.1×
2025$75.57M 11.1% down0.2×
2024$85.03M 9.6% down0.2×
2023$94.07M—0.2×
2020$4.74M 38.8% down0.0×
2019$7.73M 20.4% down0.1×
2018$9.72M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Twist Bioscience and comparable companies
CompanyTotal debtFiscal year
TG Therapeutics TGTX$253.71M2025
Praxis Precision Medicines PRAX$110.00K2025
Twist Bioscience TWST$94.99M2026
Protagonist Therapeutics PTGX$10.32M2025
Krystal Biotech KRYS$9.34M2025
10x Genomics TXG$84.36M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TWST

Twist Bioscience, figure by figure

Twist Bioscience (TWST) overview: price, valuation and scorecardAll health care companies by market value

Twist Bioscience total debt: questions and answers

How much debt does Twist Bioscience have?

Twist Bioscience (TWST) carried total debt of $94.99M at the end of fiscal 2026 (September 30, 2026). That is 25.7% higher than the $75.57M of fiscal 2025.

What are the highest and lowest total debt figures on record for Twist Bioscience?

Across the 7 fiscal years on record (2018–2026), the highest was $94.99M in fiscal 2026 and the lowest $4.74M in fiscal 2020.

How does Twist Bioscience's debt compare with its equity?

Total debt was 0.1× shareholders' equity at the end of fiscal 2026.

How is Twist Bioscience's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Twist Bioscience (TWST) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/TWST/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.